Investing

Ryan Helon, VP of investment funds at Rev1 Ventures, discusses how the firm plans to invest $30 million in growing life sciences startups within the central Ohio region. He describes the resources it and its partners provide to companies.  

The company's platform connects patients with in-network therapists and mental health providers with insurance companies.

The company partners with healthcare systems to provide tech-enabled women's health and OB/GYN services. It will use the funds to scale its reach and platform.

Also, Lupin has launched a new digital diabetes support programme.

The autism care provider will use the funds to scale nationally and deepen its investments in technology, clinical decision support, data capture and research.

CellFE, a tech-enabled cell engineering platform, and Plenful, a workflow-automation platform for pharmacy operations, also garnered investment.

It also intends to triple its consumer base.

Joaquim Cunha, executive director of Health Cluster Portugal, discusses increasing cooperation and collaboration in innovation between academia, private industry and healthcare stakeholders both internally and externally in Portugal.

The company will use the funds to enrich its technology, commercialize its MRD product and continue the development of its multi-cancer early detection offering.

The company will use the funds to expand its reach throughout hospitals in the U.S. and enhance product development.